Your browser doesn't support javascript.
loading
Genetic polymorphisms in genes of class switch recombination and multiple myeloma risk and survival: an IMMEnSE study.
Campa, Daniele; Martino, Alessandro; Macauda, Angelica; Dudzinski, Marek; Suska, Anna; Druzd-Sitek, Agnieszka; Raab, Marc-Steffen; Moreno, Victor; Huhn, Stefanie; Butrym, Aleksandra; Sainz, Juan; Szombath, Gergely; Rymko, Marcin; Marques, Herlander; Lesueur, Fabienne; Vangsted, Annette Juul; Vogel, Ulla; Kruszewski, Marcin; Subocz, Edyta; Buda, Gabriele; Iskierka-Jazdzewska, Elzbieta; Ríos, Rafael; Merz, Maximilian; Schöttker, Ben; Mazur, Grzegorz; Perrial, Emeline; Martinez-Lopez, Joaquin; Butterbach, Katja; García Sanz, Ramón; Goldschmidt, Hartmut; Brenner, Hermann; Jamroziak, Krzysztof; Reis, Rui Manuel; Kadar, Katalin; Dumontet, Charles; Watek, Marzena; Haastrup, Eva Kannik; Helbig, Grzegorz; Jurczyszyn, Artur; Jerez, Andrés; Varkonyi, Judit; Barington, Torben; Grzasko, Norbert; Zaucha, Jan Maciej; Andersen, Vibeke; Zawirska, Daria; Canzian, Federico.
Afiliación
  • Campa D; a Department of Biology , University of Pisa , Pisa , Italy.
  • Martino A; b Genomic Epidemiology Group, German Cancer Research Center (DKFZ) , Heidelberg , Germany.
  • Macauda A; a Department of Biology , University of Pisa , Pisa , Italy.
  • Dudzinski M; b Genomic Epidemiology Group, German Cancer Research Center (DKFZ) , Heidelberg , Germany.
  • Suska A; c Hematology Department , Teaching Hospital No 1 , Rzeszów , Poland.
  • Druzd-Sitek A; d Department of Hematology , Jagiellonian University Medical College , Cracow , Poland.
  • Raab MS; e Lymphoma Department , Centre of Oncology-Institute of Maria Sklodowska-Curie , Warsaw , Poland.
  • Moreno V; f Department of Internal Medicine V , Heidelberg University Hospital , Heidelberg , Germany.
  • Huhn S; g Max-Eder Research Group Experimental Therapies for Hematologic Malignancies, German Cancer Research Center (DKFZ) , Heidelberg , Germany.
  • Butrym A; h Cancer Prevention and Control Program, Catalan Institute of Oncology (ICO), IDIBELL, CIBERESP and Department of Clinical Sciences, Faculty of Medicine , University of Barcelona , Barcelona , Spain.
  • Sainz J; i Molecular Biology Laboratory, Section of Multiple Myeloma, Department of Internal Medicine V , Heidelberg University Hospital , Heidelberg , Germany.
  • Szombath G; j Department of Internal and Occupational Diseases, Hypertension and Clinical Oncology , Wroclaw Medical University , Wroclaw , Poland.
  • Rymko M; k PTS Granada , Genomic Oncology Area, GENYO. Centre for Genomics and Oncological Research: Pfizer / University of Granada / Andalusian Regional Government , Granada , Spain.
  • Marques H; l Monoclonal Gammopathies Unit, University Hospital Virgen de las Nieves , Granada , Spain.
  • Lesueur F; m Pharmacogenetics Unit. Instituto de Investigación Biosanitaria de Granada (Ibs. Granada) , Hospitales Universitarios de Granada / Universidad de Granada , Granada , Spain.
  • Vangsted AJ; n Department of Intrenal Medicine , Semmelweis University , Budapest , Hungary.
  • Vogel U; o Department of Haematology , Copernicus Town Hospital of Torun , Torun , Poland.
  • Kruszewski M; p Life and Health Sciences Research Institute (ICVS), School of Health Sciences , University of Minho , Braga , Portugal.
  • Subocz E; q INSERM U900 , Paris , France.
  • Buda G; r Institut Curie , Paris , France.
  • Iskierka-Jazdzewska E; s Mines ParisTech , Fontainebleau , France.
  • Ríos R; t PSL University , Paris , France.
  • Merz M; u Department of Hematology , Copenhagen University Hospital , Rigshospitalet , Denmark.
  • Schöttker B; v National Research Centre for the Working Environment , Denmark.
  • Mazur G; w Department of Hematology , University Hospital , Bydgoszcz , Poland.
  • Perrial E; x Department of Haematology , Military Institute of Medicine , Warsaw , Poland.
  • Martinez-Lopez J; y Hematology Unit, Department of Clinical and Experimental Medicine , University of Pisa , Pisa , Italy.
  • Butterbach K; z Department of Hematology, Copernicus Memorial Hospital , Medical University of Lodz , Lodz , Poland.
  • García Sanz R; k PTS Granada , Genomic Oncology Area, GENYO. Centre for Genomics and Oncological Research: Pfizer / University of Granada / Andalusian Regional Government , Granada , Spain.
  • Goldschmidt H; l Monoclonal Gammopathies Unit, University Hospital Virgen de las Nieves , Granada , Spain.
  • Brenner H; m Pharmacogenetics Unit. Instituto de Investigación Biosanitaria de Granada (Ibs. Granada) , Hospitales Universitarios de Granada / Universidad de Granada , Granada , Spain.
  • Jamroziak K; f Department of Internal Medicine V , Heidelberg University Hospital , Heidelberg , Germany.
  • Reis RM; aa Division of Clinical Epidemiology and Aging Research , German Cancer Research Center (DKFZ) , Heidelberg , Germany.
  • Kadar K; ab Network Aging Research (NAR) , University of Heidelberg , Heidelberg , Germany.
  • Dumontet C; j Department of Internal and Occupational Diseases, Hypertension and Clinical Oncology , Wroclaw Medical University , Wroclaw , Poland.
  • Watek M; ac Cancer Research Center of Lyon, INSERM 1052/CNRS 5286 , University of Lyon , Lyon , France.
  • Haastrup EK; ad Hospital 12 de Octubre , Complutense University, CNIO, CIBERONC , Madrid , Spain.
  • Helbig G; ab Network Aging Research (NAR) , University of Heidelberg , Heidelberg , Germany.
  • Jurczyszyn A; ae Department of Hematology , University Hospital of Salamanca , Salamanca , Spain.
  • Jerez A; f Department of Internal Medicine V , Heidelberg University Hospital , Heidelberg , Germany.
  • Varkonyi J; af National Center for Tumor Diseases (NCT) , Heidelberg , Germany.
  • Barington T; aa Division of Clinical Epidemiology and Aging Research , German Cancer Research Center (DKFZ) , Heidelberg , Germany.
  • Grzasko N; ab Network Aging Research (NAR) , University of Heidelberg , Heidelberg , Germany.
  • Zaucha JM; ag Division of Preventive Oncology , National Center for Tumor Diseases (NCT) German Cancer Research Center (DKFZ) , Heidelberg , Germany.
  • Andersen V; ah German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ) , Heidelberg , Germany.
  • Zawirska D; ai Department of Hematology , Institute of Hematology and Transfusion Medicine , Warsaw , Poland.
  • Canzian F; p Life and Health Sciences Research Institute (ICVS), School of Health Sciences , University of Minho , Braga , Portugal.
Leuk Lymphoma ; 60(7): 1803-1811, 2019 07.
Article en En | MEDLINE | ID: mdl-30633655
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Polimorfismo Genético / Biomarcadores de Tumor / Cambio de Clase de Inmunoglobulina / Mieloma Múltiple Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Leuk Lymphoma Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2019 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Polimorfismo Genético / Biomarcadores de Tumor / Cambio de Clase de Inmunoglobulina / Mieloma Múltiple Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Leuk Lymphoma Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2019 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Estados Unidos